Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D6DPI4
|
|||
| Drug Name |
ABI-H2158
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Hepatitis B [ICD-11: 1E51; ICD-10: B18.1] | Phase 2 | [1] | |
| Company |
Assembly Biosciences
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Hepatitis B virus Capsid protein (HBV C) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04398134) A Study of ABI-H2158-containing Regimens in Participants With Chronic Hepatitis B Virus Infection. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Assembly Biosciences. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.